All filters
E-Posters
Number, Type And Cost Of Microbiological Assays During HIV Pre-Exposure Prophylaxis: The Experience Of A French Hospital
M. Morgat
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 Results
R. D'Amico
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action
E. Magongo
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWH
D. Armenia
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patients
C. Valente
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in Norway
R. Leiva
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or Durability
J. Jeffrey
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV evolution in patients initiating antiretroviral therapy during primary infection
B. Abdi
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug Resistance
L. Kostrikis
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
A changing of HIV-1 genetic diversity in Russia during the last two decades: increase of the recombinants prevalence
A. Antonova
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Phylogenetic analyses applied to the study of transmission variants in a HIV-1 positive couple
A. Bergna
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Unexpected rising in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
M. Alkhatib
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Session 6 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Session 4 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2019
Videos
Session 5 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
HBV Cure Science 101 - ICE-HBV - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Session 2 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Session 1 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Opening Session - Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Management of HBV - Test & Treat Strategy - Hailemichael Desalegn
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Inclusion of Vulnerable Groups in HCV Prevention, Testing, and Treatment in the African Region - Niklas Luhmann
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Résistance du VHB aux Inhibiteurs Nucléo(s)tidiques de la Transcriptase Inverse (INTI) et son Impact sur l’Aantigène de Surface (AgHBs) chez des Patients Co-Infectés VHB-VIH à Abidjan - Leto Olivier Gogbe
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Access to Treatment in Africa - Oriel Fernandes
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Management of HBV in Children - Manal El-Sayed
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020